These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 4875573

  • 1. [First clinical trails with the "medium tranquilizer" mesoridazine].
    Rhomberg F, Staehelin B.
    Schweiz Med Wochenschr; 1967 Apr 22; 97(16):521-5. PubMed ID: 4875573
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Therapy of functional cardiovascular and gastrointestinal disorders using NC-123].
    de Barros OM, Bourroul G.
    Hospital (Rio J); 1968 Sep 22; 74(3):955-62. PubMed ID: 5310131
    [No Abstract] [Full Text] [Related]

  • 4. A controlled study of mesoridazine: an effective treatment for schizophrenia.
    McIndoo MV.
    South Med J; 1971 May 22; 64(5):592-6. PubMed ID: 4929612
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Mesoridazine, a new medium tranquilizing agent in internal medicine].
    Rummelhardt K.
    Wien Med Wochenschr; 1967 May 27; 117(21):542-4. PubMed ID: 4869522
    [No Abstract] [Full Text] [Related]

  • 8. [Treatment of stuttering with a new medium tranquilizer mesoridazine (Lidanil)].
    Daskalov D.
    Praxis; 1969 May 13; 58(19):630-5. PubMed ID: 4895699
    [No Abstract] [Full Text] [Related]

  • 9. [Dipotassium chlorazepate. Clinical reports on a new anxiolytic].
    Hofmann KW, Manach J, Sögtrop HH.
    Arzneimittelforschung; 1970 Jan 13; 20(1):130-7. PubMed ID: 4914611
    [No Abstract] [Full Text] [Related]

  • 10. [Treatment of functional cardiovascular and gastrointestinal disorders with NC-123].
    de Barros OM, Bourroul G.
    Hospital (Rio J); 1968 Sep 13; 74(3):956-62. PubMed ID: 5303778
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Study of a new neuroleptic in a department of general medicine of adults: perimetazine (1317 A.N.)].
    Volle L, Baudinot J, Lardet C, Frairot A.
    Lyon Med; 1970 May 24; 223(21):1083-6. PubMed ID: 5421811
    [No Abstract] [Full Text] [Related]

  • 14. [Pilot study on the treatment of anxiety neuroses with mesoridazine].
    Hetem G.
    Hospital (Rio J); 1970 Mar 24; 77(3):993-1003. PubMed ID: 5315126
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Action of Temesta(Lorazepam)as a anxiolytic in hay fever].
    Miller M.
    Acta Allergol; 1974 Jun 24; 29(3):176-84. PubMed ID: 4603314
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Butaperazine in chronic schizophrenic patients: a doubled-blinf study.
    Brotman RK, Muzekari LH, Shanken PM.
    Curr Ther Res Clin Exp; 1969 Jan 24; 11(1):5-8. PubMed ID: 4387485
    [No Abstract] [Full Text] [Related]

  • 19. [Treatment of personality and behavior disorders in childhood epilepsy with Neuleptil].
    Nagayama T, Takeshita K, Kurakawa T.
    No To Shinkei; 1967 Sep 24; 19(9):935-40. PubMed ID: 4866508
    [No Abstract] [Full Text] [Related]

  • 20. Some effects of mesoridazine (TPS-23) on chronic psychiatric patients.
    Douglas KW, Hindley JP, Kerin MT.
    Dis Nerv Syst; 1967 Feb 24; 28(2):113-7. PubMed ID: 6021590
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.